Danaher Co. (NYSE:DHR) Shares Acquired by Keel Point LLC

Keel Point LLC lifted its holdings in Danaher Co. (NYSE:DHRFree Report) by 8.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,898 shares of the conglomerate’s stock after buying an additional 1,394 shares during the period. Keel Point LLC’s holdings in Danaher were worth $4,338,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of DHR. Gilbert & Cook Inc. grew its holdings in shares of Danaher by 2.5% during the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after purchasing an additional 42 shares during the period. Grimes & Company Inc. lifted its stake in Danaher by 0.6% in the fourth quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after acquiring an additional 43 shares during the last quarter. Dakota Community Bank & Trust NA increased its holdings in Danaher by 16.4% in the fourth quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock valued at $73,000 after buying an additional 45 shares during the last quarter. Howard Capital Management Group LLC raised its stake in Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after buying an additional 48 shares in the last quarter. Finally, Spinnaker Trust raised its stake in Danaher by 1.2% in the fourth quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock valued at $988,000 after buying an additional 50 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on DHR shares. JPMorgan Chase & Co. cut their target price on shares of Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a report on Tuesday, April 22nd. Royal Bank of Canada reiterated an “outperform” rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. Jefferies Financial Group cut their price objective on shares of Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research report on Tuesday, April 22nd. Wells Fargo & Company cut their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Finally, Barclays upped their price objective on shares of Danaher from $205.00 to $215.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 22nd. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $264.40.

Get Our Latest Research Report on Danaher

Danaher Trading Up 0.2 %

NYSE:DHR opened at $199.32 on Thursday. Danaher Co. has a 12-month low of $171.00 and a 12-month high of $281.70. The firm has a market capitalization of $142.65 billion, a P/E ratio of 37.75, a P/E/G ratio of 2.66 and a beta of 0.86. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The business has a 50 day simple moving average of $200.30 and a 200 day simple moving average of $223.12.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. Equities research analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 25th. Shareholders of record on Friday, March 28th were paid a dividend of $0.32 per share. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend was Friday, March 28th. This represents a $1.28 annualized dividend and a yield of 0.64%. Danaher’s dividend payout ratio (DPR) is presently 24.85%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.